Neuromyelitis Optica Spectrum Disorder

• CLINICAL_TRIALS research · 2016-08-09
  Clinical Trial Update: Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

  This clinical trial update describes multimodal MRI approaches for studying multiple sclerosis and neuromyelitis optica spectrum disorder.

• CLINICAL_TRIALS trial_result · 2016-06-22
  Clinical Trial Update: Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients [Phase 4]

  Phase 4 clinical trial assessing the efficacy and safety of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum dis…

• CLINICAL_TRIALS trial_result · 2015-05-29
  Clinical Trial Update: Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations [Phase 1]

  Phase 1 study evaluating bevacizumab for acute neuromyelitis optica exacerbations; the trial completed and posted results in 2015.

• CLINICAL_TRIALS trial_result · 2013-12-27
  Clinical Trial Update: Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders [Phase 4]

  Phase 4 trial evaluating the efficacy and safety of mitoxantrone in patients with refractory neuromyelitis optica and related disorders.

• FDA approval · 2012-12-21
  FDA Approved: SOLIRIS — Supplemental Application (Alexion Pharmaceuticals Inc.)

  FDA approved a supplemental application for SOLIRIS (eculizumab) submitted by Alexion Pharmaceuticals, resulting in changes to the product l…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.